US FDA Recommends Pause On Johnson & Johnson's Single Dose Vaccine Following Blood Clot Cases
(A picture of vaccine vials from Johnson and Johnson)
The United States Food and Drug Administration has recommended a pause over the use of Johnson and Johnson's single use Covid-19 vaccine over six patients developing a rare and severe type of blood clot after receiving the vaccine.
Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine. We are recommending a pause in the use of this vaccine out of an abundance of caution.— U.S. FDA (@US_FDA) April 13, 2021
As per a series of tweets by the FDA, 68 lakh doses of the vaccine have been administered to patients, out of which a rare and severe type of blood clot has been reported among six of them.